Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity

被引:210
作者
Jansson, Patric J. [2 ,3 ]
Sharpe, Philip C. [1 ]
Bernhardt, Paul V. [1 ]
Richardson, Des R. [2 ,3 ]
机构
[1] Univ Queensland, Ctr Met Biol, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia
[2] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
POTENT IRON CHELATORS; OXIDATIVE STRESS; ANTIPROLIFERATIVE ACTIVITY; RIBONUCLEOTIDE REDUCTASE; CANCER-CELLS; TRANSFERRIN; GLUTATHIONE; AGENTS; INHIBITION; HYDRAZONE;
D O I
10.1021/jm100561b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The novel chelators 2-acetylpyridine-4,4-dimethyl-3-thiosemicarbazone (HAp44mT) and di-2-pyridyl-ketone-4,4-dimethyl-3-thiosemicarbazone (HDp44mT) have been examined to elucidate the structure activity relationships necessary to form copper (Cu) complexes with pronounced antitumor activity. Electrochemical studies demonstrated that the Cu complexes of these ligands had lower redox potentials than their iron complexes. Moreover, the Cu complexes where the ligand/metal ratio was 1:1 rather than 2:1 had significantly higher intracellular oxidative properties and antitumor efficacy. Interestingly, the 2:1 complex was shown to dissociate to give significant amounts of the 1:1 complex that could be the major cytotoxic effector. Both types of Cu complex showed significantly more antiproliferative activity than the ligand alone. We also demonstrate the importance of the inductive effects of substituents on the carbonyl group of the parent ketone, which influence the Cu-II/1 redox potentials because of their proximity to the metal center. The structure-activity relationships described are important for the design of potent thiosemicarbazone Cu complexes.
引用
收藏
页码:5759 / 5769
页数:11
相关论文
共 58 条
[1]   Neurodegenerative diseases and oxidative stress [J].
Barnham, KJ ;
Masters, CL ;
Bush, AI .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) :205-214
[2]   Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity [J].
Bemhardt, Paul V. ;
Sharpe, Philip C. ;
Islam, Mohammad ;
Lovejoy, David B. ;
Kalinowski, Danuta S. ;
Richardson, Des R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :407-415
[3]   Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues [J].
Bernhardt, PV ;
Caldwell, LM ;
Chaston, TB ;
Chin, P ;
Richardson, DR .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2003, 8 (08) :866-880
[4]  
BLAIR D, 1961, TALANTA, P163
[5]   Iron chelators in cancer chemotherapy [J].
Buss, JL ;
Greene, BT ;
Turner, J ;
Torti, FM ;
Torti, SV .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (15) :1623-1635
[6]   Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells [J].
Daniel, KG ;
Gupta, P ;
Harbach, RH ;
Guida, WC ;
Dou, QP .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (06) :1139-1151
[7]  
Farrugia L.J., 1997, J. Appl. Crystallogr., V30, P565, DOI [10.1107/S0021889897003117, DOI 10.1107/S0021889897003117]
[8]  
Fenton H.J.H., 1876, Chem News, V33, P190
[9]  
GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558